ANTHONY B. EVNIN - 09 Jun 2021 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Danielle Holland, attorney-in fact
Issuer symbol
N/A
Transactions as of
09 Jun 2021
Net transactions value
$0
Form type
4
Filing time
09 Jun 2021, 17:18:02 UTC
Previous filing
02 Jun 2021
Next filing
11 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVEO Stock Option (right to buy) Award $0 +12,500 $0.000000 12,500 09 Jun 2021 Common Stock 12,500 $7.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in twelve equal monthly installments beginning July 1, 2021, subject to the Reporting Person's continued service to the Company.

Remarks:

Exhibit Index: 24.1 Power of Attorney